Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

128.30 -4.38 (-3.30%)
Streaming Delayed Price Updated: 11:50 AM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
Abbott Laboratories Remains In Favor With London Investment Manager, New Filing Shows
Via The Motley Fool
Topics Regulatory Compliance
These S&P500 stocks are gapping in today's session
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session. 
Via Chartmill
1 No-Brainer Dividend Stock to Buy and Hold Forever
This is about as safe as a dividend can be. 
Via The Motley Fool
Abbott Tightens Annual Sales Forecast As Q3 Sales Miss Expectations
Abbott stock fell as Q3 sales missed estimates and 2025 earnings guidance was narrowed despite solid growth in medical devices. 
Via Benzinga
Topics Earnings
Abbott Labs Skids On Mixed Third-Quarter Report, But One Segment Shined
Notably, the company reaffirmed its sales guidance and the midpoint of its earnings outlook. 
Via Investor's Business Daily
What's going on in today's pre-market session: S&P500 movers
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top S&P500 gainers and losers in today's pre-market session. 
Via Chartmill
Abbott Laboratories (NYSE:ABT) Trims 2025 Outlook After Q3 Earnings
Abbott Labs Q3 2025 results met EPS views, but trimmed full-year guidance. Sales grew 6.9% as the healthcare giant navigates a complex market. 
Via Chartmill
Abbott Laboratories (NYSE:ABT) Reports Q3 In Line With Expectations
Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 6.9% year on year to $11.37 billion. Its non-GAAP profit of $1.30... 
Via StockStory
Stock Market Today: Nasdaq, Dow Jones Futures Rise, Bank Of America, Morgan Stanley, Abbott In Focus—Analyst Warns US 'Going Broke Slowly'
U.S. stock futures advanced on Wednesday following Tuesday’s mixed close. Futures of major benchmark indices were higher. 
Via Benzinga
Topics Stocks
Earnings Scheduled For October 15, 2025
 
Via Benzinga
Dow Jumps Over 200 Points Following Strong Bank Earnings: Investor Fear Eases Slightly, But Greed Index Remains In 'Fear' Zone
Dow Jones gains, but trade tensions limit enthusiasm. Wells Fargo, Citi, JPMorgan, and Goldman Sachs beat expectations. 
Via Benzinga
Topics Stocks World Trade
Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Wednesday
US stock futures higher, BAC, PZZA, MS expected to report earnings, ASML reports better-than-expected bookings, ABT to report earnings. 
Via Benzinga
A Look Ahead: Abbott Laboratories's Earnings Forecast
 
Via Benzinga
Abbott Laboratories (ABT) Q3 Earnings Report Preview: What To Look For
Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be reporting earnings this Wednesday morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Abbott Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
 
Via Benzinga
Dow Jones Soars on Trump's Tariff Remarks, Signaling Market Volatility Amidst Trade Policy Shifts
New York, NY – October 13, 2025 – The Dow Jones Industrial Average has experienced significant upward momentum in recent months, notably jumping by hundreds of points on multiple occasions in early... 
Via MarketMinute
Topics Economy Government Stocks
Retail Investors' Top Stocks With Earnings This Week: Fastenal, ASML, TSMC And More
Retail investors are preparing for the kick-off of the Q3 earnings season, with big banks and other top stocks reporting this week. 
Via Benzinga
A Congress Member Sold Up To $300K In A.O. Smith Stock: Here's What You Need To Know
 
Via Benzinga
2 Cash-Producing Stocks Worth Your Attention and 1 We Avoid
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Forecasting The Future: 12 Analyst Projections For Abbott Laboratories
 
Via Benzinga
3 Dividend Stocks to Double Up On Right Now
The time is right for buying more of these great dividend stocks. 
Via The Motley Fool
Topics Economy Energy
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Breakthrough in Alzheimer’s Diagnostics: University of Liverpool Unveils Low-Cost, Handheld AI Blood Test
In a monumental stride towards democratizing global healthcare, researchers at the University of Liverpool have announced the development of a pioneering low-cost, handheld, AI-powered blood test... 
Via TokenRing AI
Topics Artificial Intelligence
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
2 Profitable Stocks to Consider Right Now and 1 We Find Risky
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
1 Top ETF I Wouldn't Hesitate to Invest $1,000 Into Right Now
This fund makes it easy to invest in the top dividend stocks. 
Via The Motley Fool
Topics ETFs Stocks
Abbott India Limited: A Deep Dive into its Robust Forecast and Valuation Outlook Amidst a Thriving Indian Pharma Market
Mumbai, India – September 27, 2025 – Abbott India Limited (NSE: ABBOTINDIA), a prominent player in the Indian pharmaceutical sector, is exhibiting a robust financial trajectory and a promising... 
Via MarketMinute
Topics Economy Intellectual Property
Abbott Laboratories (NYSE:ABT) Passes the Caviar Cruise Quality Investing Screen
Discover Abbott Laboratories (ABT), a top Caviar Cruise screen pick. This healthcare leader excels in profitability, financial health, and cash flow, making it a strong long-term quality investment. 
Via Chartmill
1 Unpopular Stock That Deserves Some Love and 2 We Avoid
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Topics Retirement
Abbott Laboratories (NYSE:ABT) Presents a Technical Breakout Setup for Investors
Abbott Laboratories (ABT) is a technical breakout candidate, showing a strong uptrend and a perfect consolidation setup, suggesting a potential upward move. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.